Largest psilocybin study continues to grow
COMPASS Pathways plc announces financial results and business highlights for the second quarter 2021 The
August 11, 2021
COMPASS Pathways plc announces financial results and business highlights for the second quarter 2021 The
Mindset Pharma Announces Preclinical Results Demonstrating Superior Efficacy, Safety and Shorter Duration of Action Across
Filament Health Is the First Public Company to be Issued a Patent for Extraction of
PsiloThera Announces Launch of Quantum Technology Drug Development Program PsiloThera Inc. launched a quantum technology
Novamind Opens 5th Location Specialized in Integrative Psychiatry for Patients with Treatment-Resistant Conditions From 4
atai Life Sciences launches InnarisBio, in partnership with the University of Queensland, with the aim
Novamind Has Applied to Have its Common Shares Posted for Trading on the OTCQB in
Danielle Schlosser joins COMPASS Pathways from Verily Life Sciences to lead clinical innovation and therapist
Red Light Holland Files New Patent: Technology and Devices for Monitoring Information and Influencing Behavior
Expert: Psilocybin Treatment May Support Patients With Obesity Who Have Tried Everything, Need Further Support
Mindset Pharma Announces Appointment of Clinician Scientist, Dr. Ishrat Husain, to Scientific Advisory Board
Leading U.S.-Based Psychedelic Healthcare VC Fund Launches with $35 Million Raised to Tackle the Growing
Knowde Group Inc.™ Enters Into a Strategic Partnership with LMC Manna Research to Drive Quality
Red Light Holland Expected Merger Partner Creso Pharma Completes Acquisition of Halucenex Life Sciences Inc
Florida startup treating illness with magic mushrooms receives $2.5 million
Wesana Health Announces Definitive Agreement to Acquire PsyTech Inc. Former Chicago Blackhawks player Daniel Carcillo
Optimi Health Joins First Psychedelic Exchange Traded Fund PSYK, the world’s first psychedelic ETF that
Cybin Expands to Europe and Provides Update on Intellectual Property Portfolio After partnering with Greenbrook
Liam Payne becomes the latest star to invest in a depression treatment made from psychedelic
Mindset Pharma Announces Additional Preclinical Results Suggesting Superior Efficacy and Improved Safety in Head-to-Head Comparison
A New Vaccine Against Depression? | MYND Life Sciences While many psychedelics companies are developing
Maxim Group Gives Buy Rating To 10 Psychedelic Stocks: Compass, MindMed, Cybin, Field Trip And
Former Head Of Psychiatry Products At FDA Joins Psychedelic Drug Developer Cybin PDF of article
Maxim Group initiates coverage of Mindset Pharma with a ‘Buy’ rating and price target of